Literature DB >> 26456305

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).

Simon D Brandt1, Pierce V Kavanagh2, Folker Westphal3, Alexander Stratford4, Simon P Elliott5, Khoa Hoang6, Jason Wallach7, Adam L Halberstadt8.   

Abstract

1-Propionyl-d-lysergic acid diethylamide hemitartrate (1P-LSD) has become available as a 'research chemical' in the form of blotters and powdered material. This non-controlled derivative of d-lysergic acid diethylamide (LSD) has previously not been described in the published literature despite being closely related to 1-acetyl-LSD (ALD-52), which was developed in the 1950s. This study describes the characterization of 1P-LSD in comparison with LSD using various chromatographic and mass spectrometric methods, infrared and nuclear magnetic resonance spectroscopy. An important feature common to LSD and other serotonergic hallucinogens is that they produce 5-HT2A -receptor activation and induce the head-twitch response (HTR) in rats and mice. In order to assess whether 1P-LSD displays LSD-like properties and activates the 5-HT2A receptor, male C57BL/6 J mice were injected with vehicle (saline) or 1P-LSD (0.025-0.8 mg/kg, IP) and HTR assessed for 30 min using magnetometer coil recordings. It was found that 1P-LSD produced a dose-dependent increase in HTR counts, and that it had ~38% (ED50  = 349.6 nmol/kg) of the potency of LSD (ED50  = 132.8 nmol/kg). Furthermore, HTR was abolished when 1P-LSD administration followed pretreatment with the selective 5-HT2A receptor antagonist M100907 (0.1 mg/kg, SC), which was consistent with the concept that the behavioural response was mediated by activation of the 5-HT2A receptor. These results indicate that 1P-LSD produces LSD-like effects in mice, consistent with its classification as a serotonergic hallucinogen. Nevertheless, the extent to which 1P-LSD might show psychoactive effects in humans similar to LSD remains to be investigated.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  5-HT2A receptor; LSD; lysergamides; new psychoactive substances; psychedelics

Mesh:

Substances:

Year:  2015        PMID: 26456305      PMCID: PMC4829483          DOI: 10.1002/dta.1884

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  48 in total

1.  Lysergic acid diethylamide and related substances.

Authors:  E ROTHLIN
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

Review 2.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Authors:  Franz X Vollenweider; Michael Kometer
Journal:  Nat Rev Neurosci       Date:  2010-08-18       Impact factor: 34.870

3.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Flashback to the 1960s: LSD in the treatment of autism.

Authors:  Jeff Sigafoos; Vanessa A Green; Chaturi Edrisinha; Giulio E Lancioni
Journal:  Dev Neurorehabil       Date:  2007 Jan-Mar       Impact factor: 2.308

Review 5.  From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.

Authors:  David E Smith; Glenn E Raswyck; Leigh Dickerson Davidson
Journal:  J Psychoactive Drugs       Date:  2014 Jan-Mar

6.  Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.

Authors:  A P Monte; D Marona-Lewicka; A Kanthasamy; E Sanders-Bush; D E Nichols
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

7.  AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis.

Authors:  Simon P Elliott; Simon D Brandt; Sally Freeman; Roland P Archer
Journal:  Drug Test Anal       Date:  2012-10-05       Impact factor: 3.345

8.  Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.

Authors:  J Cai; J Henion
Journal:  J Anal Toxicol       Date:  1996 Jan-Feb       Impact factor: 3.367

Review 9.  Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.

Authors:  D E Nichols; A Monte; X Huang; D Marona-Lewicka
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

10.  The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.

Authors:  Clinton E Canal; Uade B Olaghere da Silva; Paul J Gresch; Erin E Watt; Elaine Sanders-Bush; David C Airey
Journal:  Psychopharmacology (Berl)       Date:  2010-02-19       Impact factor: 4.530

View more
  22 in total

1.  Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-05-10       Impact factor: 3.345

2.  Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

Authors:  Joseph J Palamar; Austin Le
Journal:  Hum Psychopharmacol       Date:  2019-03-06       Impact factor: 1.672

Review 3.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

Authors:  Simon D Brandt; Pierce V Kavanagh; Brendan Twamley; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; Landon M Klein; John D McCorvy; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-07-27       Impact factor: 3.345

6.  Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Alexander Stratford; Simon P Elliott; Geraldine Dowling; Jason Wallach; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2019-06-18       Impact factor: 3.345

Review 7.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

8.  Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Authors:  Adam L Halberstadt; Muhammad Chatha; Stephen J Chapman; Simon D Brandt
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

9.  Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Tristan Colestock; Timothy E Burrow; Stephen J Chapman; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-06-06       Impact factor: 3.345

10.  Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Authors:  Adam L Halberstadt; Landon M Klein; Muhammad Chatha; Laura B Valenzuela; Alexander Stratford; Jason Wallach; David E Nichols; Simon D Brandt
Journal:  Psychopharmacology (Berl)       Date:  2018-10-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.